Q3 FY2026 · ended Sep 30, 2026 · Revenue $74.08M, +50.3% YoY · Filed Nov 3, 2026
Strata Critical Medical, Inc. (SRTA) files with the SEC under industry code 4700, Transportation Services. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $74.1 million and a net loss of $7.6 million. Free cash flow was $9.1 million. As of Sep 30, 2026 it held $41.6 million in cash and investments and $3.6 million in total debt.
Revenue
$74.08M
+50.3% vs year-ago quarter
Net income
$-7.62M
-113.3% vs year-ago quarter
Operating cash flow
$9.46M
+125.4% vs year-ago quarter
Free cash flow
$9.06M
+122.5% vs year-ago quarter
EPS
$-0.09
-112.9% vs year-ago quarter
Dividend per share
None
Shares outstanding
89.32M
+3.4% vs year-ago quarter
Net cash
$38.02M
Q3 FY2026
Operating margin
-6.6%
TTM
Company profile
- Industry
- Transportation Services (SIC 4700)
- Listed as
- SRTA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Accelerated filer
- SEC CIK
- 1779128
- Former names
- Blade Air Mobility, Inc. (until Aug 18, 2025); Experience Investment Corp. (until May 7, 2021)
Other Transportation Services companies
- Booking Holdings Inc. BKNG
- Expedia Group, Inc. EXPE
- XPO, Inc. XPO
- Gatx Corp GATX
- GXO Logistics, Inc. GXO
- Hafnia Ltd HAFN
- RXO, Inc. RXO
- MakeMyTrip Ltd MMYT
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $74.1M | $72.5M | $67.4M | $66.8M | $49.3M |
| Operating income | -$3.8M | -$5.4M | -$3.0M | -$6.4M | -$5.6M |
| Net income | -$7.6M | -$10.5M | $2.2M | -$8.8M | $57.4M |
| Diluted EPS | -$0.09 | -$0.12 | $0.03 | -$0.10 | $0.70 |
| Operating cash flow | $9.5M | $5.7M | $3.9M | -$8.3M | -$37.3M |
| Free cash flow | $9.1M | $3.2M | -$1.3M | -$10.2M | -$40.2M |
| Total assets | $328.9M | $332.7M | $327.6M | $325.5M | $335.1M |
| Total liabilities | $52.5M | $53.4M | $41.9M | $46.4M | $52.1M |
| Stockholders' equity | $276.4M | $279.3M | $285.7M | $279.1M | $283.0M |
| Cash and investments | $41.6M | $22.8M | $58.8M | $61.2M | $75.9M |
| Total debt | $3.6M | $4.3M | $4.5M | $3.3M | $3.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | May 28, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
All 574 Strata Critical Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.